investorscraft@gmail.com

Intrinsic Value8088 Investment Holdings Limited (8088.HK)

Previous CloseHK$0.06
Intrinsic Value
Upside potential
Previous Close
HK$0.06

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2021 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

AID Life Science Holdings Limited operates as a specialized investment manager, providing a suite of financial services primarily in Hong Kong with an international scope. Its core revenue model is derived from asset management, investment advisory, and corporate services, supplemented by fund administration and wealth management offerings. The company also maintains a portfolio of available-for-sale investments, which contributes to its earnings. Operating within the highly competitive and regulated financial services sector, the firm positions itself as a niche player catering to specific client needs rather than competing with large-scale institutional asset managers. Its market position is characterized by its smaller scale and focused service offerings, which may appeal to a targeted clientele seeking personalized investment management and advisory services in the Asian financial markets.

Revenue Profitability And Efficiency

The company reported revenue of HKD 19.98 million for FY 2021. Despite this modest top-line figure, it demonstrated strong profitability with net income of HKD 18.53 million, indicating efficient cost management. However, operating cash flow was negative at HKD -9.48 million, suggesting potential challenges in cash generation from core operations during this period.

Earnings Power And Capital Efficiency

The company generated diluted EPS of HKD 0.0335, reflecting its earnings capacity relative to its equity base. The significant disparity between revenue and net income suggests substantial non-operating income sources, likely from its investment portfolio. Capital expenditures were minimal at HKD -78,000, indicating a capital-light business model focused primarily on financial assets rather than physical infrastructure.

Balance Sheet And Financial Health

The balance sheet shows HKD 29.51 million in cash against total debt of HKD 168.06 million, indicating a leveraged position. The high debt level relative to cash reserves warrants attention, though the company's profitability provides some capacity to service obligations. The composition of assets appears heavily weighted toward financial investments rather than operating assets.

Growth Trends And Dividend Policy

No dividend was distributed during the period, consistent with the company's focus on retaining earnings. The financial profile suggests a strategy oriented toward investment growth rather than income distribution to shareholders. Historical trends would be needed to assess longer-term growth patterns and capital allocation priorities.

Valuation And Market Expectations

With a reported market capitalization of zero, this likely indicates either data unavailability or a delisted status. The beta of 0.19 suggests lower volatility relative to the market, but without valid market cap data, conventional valuation metrics cannot be meaningfully calculated or interpreted for this period.

Strategic Advantages And Outlook

The company's strategic position lies in its specialized investment management services and portfolio holdings. Its outlook depends on investment performance and ability to navigate competitive financial markets. The negative operating cash flow and leveraged balance sheet present challenges that management must address through improved operational efficiency and prudent capital management.

Sources

Company filingsFinancial data provider

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2022202320242025202620272028202920302031203220332034203520362037203820392040204120422043204420452046

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount